skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 196  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: The Lancet remove subject: Vaccines remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
Material Type:
Article
Add to My Research

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

The Lancet (British edition), 2021-05, Vol.397 (10287), p.1809-1818 [Peer Reviewed Journal]

2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00943-0 ;PMID: 33964223

Full text available

2
Viral gastroenteritis
Material Type:
Article
Add to My Research

Viral gastroenteritis

The Lancet (British edition), 2018-07, Vol.392 (10142), p.175-186 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31128-0 ;PMID: 30025810

Full text available

3
Global health 2035: a world converging within a generation
Material Type:
Article
Add to My Research

Global health 2035: a world converging within a generation

The Lancet (British edition), 2013-12, Vol.382 (9908), p.1898-1955 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2015 INIST-CNRS ;Copyright Elsevier Limited Dec 7, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)62105-4 ;PMID: 24309475 ;CODEN: LANCAO

Full text available

4
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial
Material Type:
Article
Add to My Research

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2014-06, Vol.383 (9935), p.2136-2143 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 21, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)62630-6 ;PMID: 24629994 ;CODEN: LANCAO

Full text available

5
RTS,S malaria vaccine pilots in three African countries
Material Type:
Article
Add to My Research

RTS,S malaria vaccine pilots in three African countries

The Lancet (British edition), 2019-04, Vol.393 (10182), p.1685-1685 [Peer Reviewed Journal]

2019 Elsevier Ltd ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)30937-7 ;PMID: 31034365

Full text available

6
Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access
Material Type:
Article
Add to My Research

Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access

The Lancet, 2020-09, Vol.396 (10254), p.800-802 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31873-0 ;PMID: 32910908

Digital Resources/Online E-Resources

7
Serotype replacement in disease after pneumococcal vaccination
Material Type:
Article
Add to My Research

Serotype replacement in disease after pneumococcal vaccination

The Lancet (British edition), 2011-12, Vol.378 (9807), p.1962-1973 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 3-Dec 9, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)62225-8 ;PMID: 21492929 ;CODEN: LANCAO

Full text available

8
Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost?
Material Type:
Article
Add to My Research

Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost?

The Lancet (British edition), 2013-04, Vol.381 (9875), p.1417-1429 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 20, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)60648-0 ;PMID: 23582723 ;CODEN: LANCAO

Full text available

9
Challenges ahead for the new head of Gavi
Material Type:
Article
Add to My Research

Challenges ahead for the new head of Gavi

The Lancet (British edition), 2024-01, Vol.403 (10423), p.234-234 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00092-8 ;PMID: 38246196

Full text available

10
What next for a COVID-19 intellectual property waiver?
Material Type:
Article
Add to My Research

What next for a COVID-19 intellectual property waiver?

The Lancet (British edition), 2021-05, Vol.397 (10288), p.1871-1872 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01151-X ;PMID: 34022975

Full text available

11
DNA vaccines join the fight against COVID-19
Material Type:
Article
Add to My Research

DNA vaccines join the fight against COVID-19

The Lancet (British edition), 2022-04, Vol.399 (10332), p.1281-1282 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00524-4 ;PMID: 35366995

Full text available

12
Decoupling of omicron variant infections and severe COVID-19
Material Type:
Article
Add to My Research

Decoupling of omicron variant infections and severe COVID-19

The Lancet (British edition), 2022-03, Vol.399 (10329), p.1047-1048 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00109-X ;PMID: 35189080

Full text available

13
Viral pneumonia
Material Type:
Article
Add to My Research

Viral pneumonia

The Lancet (British edition), 2011-04, Vol.377 (9773), p.1264-1275 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 9-Apr 15, 2011 ;Copyright © 2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61459-6 ;PMID: 21435708 ;CODEN: LANCAO

Full text available

14
COV-BOOST: evidence to support rapid booster deployment
Material Type:
Article
Add to My Research

COV-BOOST: evidence to support rapid booster deployment

The Lancet (British edition), 2021-12, Vol.398 (10318), p.2209-2211 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;Crown Copyright © 2022 Published by Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02799-9 ;PMID: 34922657

Full text available

15
The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery
Material Type:
Article
Add to My Research

The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery

The Lancet (British edition), 2023-08, Vol.402 (10401), p.510-512 [Peer Reviewed Journal]

2023 World Health Organization ;2023. World Health Organization ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)01468-X ;PMID: 37478887

Full text available

16
Closing the global vaccine equity gap: equitably distributed manufacturing
Material Type:
Article
Add to My Research

Closing the global vaccine equity gap: equitably distributed manufacturing

The Lancet (British edition), 2022-05, Vol.399 (10339), p.1924-1926 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00793-0 ;PMID: 35533706

Full text available

17
Revitalising the right to health is essential to securing better health for all
Material Type:
Article
Add to My Research

Revitalising the right to health is essential to securing better health for all

The Lancet (British edition), 2024-04, Vol.403 (10434), p.1315-1318 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00582-8 ;PMID: 38522450

Digital Resources/Online E-Resources

18
Backsliding on human rights and equity in the Pandemic Accord
Material Type:
Article
Add to My Research

Backsliding on human rights and equity in the Pandemic Accord

The Lancet (British edition), 2023-06, Vol.401 (10393), p.2019-2021 [Peer Reviewed Journal]

2023 Elsevier Ltd ;2023. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)01118-2 ;PMID: 37271154

Full text available

19
Vaccine shortages prompt changes to COVAX strategy
Material Type:
Article
Add to My Research

Vaccine shortages prompt changes to COVAX strategy

The Lancet (British edition), 2021-10, Vol.398 (10310), p.1474-1474 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02309-6 ;PMID: 34688360

Full text available

20
Calls for independent evaluation of ACT-A welcomed
Material Type:
Article
Add to My Research

Calls for independent evaluation of ACT-A welcomed

The Lancet (British edition), 2022-05, Vol.399 (10340), p.2006-2006 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00974-6 ;PMID: 35644147

Full text available

Results 1 - 20 of 196  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1989  (14)
  2. 1989 To 1996  (54)
  3. 1997 To 2004  (47)
  4. 2005 To 2013  (48)
  5. After 2013  (34)
  6. More options open sub menu

Searching Remote Databases, Please Wait